Search
Now showing items 1-2 of 2
CES1 and SLC6A2 genetic variants as predictors of response to methylphenidate in autism spectrum disorders
(Dove Medical Press, 2022-11)
Purpose
Autistic spectrum disorders (ASD) children and adolescents usually present comorbidities, with 40–70% of them affected by attention deficit hyperactivity disorders (ADHD). The first option of ...
Pharmacogenetic interventions improve the clinical outcome of treatment-resistant autistic spectrum disorder sufferers
(MDPI, 2022-05)
BACKGROUND: Autistic spectrum disorders (ASD) are severe neurodevelopmental alterations characterised by deficits in social communication and repetitive and restricted behaviours. About a third of ...